• Clinical Insights

September 2023 drug trend report

Sep 1st, 2023

Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market.

Brand name drug launches*


  • Indicated for: Treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.
  • Dosage form: Extended-release injectable.
  • Status: Genoa Healthcare has been selected to participate in the Brixadi™ limited distribution network. Brixadi™ will be available at select Genoa pharmacies in early September, with availability at additional locations soon to follow. Please reach out to your local Genoa pharmacist for more information.

Zurzuvae™ (zuranolone)

  • Indicated for: Treatment of depressive symptoms in women with post-partum depression.
  • Dosage form: Once-daily, oral, 14-day medicine.
  • Status: Expected fourth quarter of 2023.

Generic drug launches*

Spiriva® HandiHaler (Tiotropium Bromide)

  • Indicated for: Controlling symptoms of chronic obstructive pulmonary disease (COPD).
  • Status: Available now.

Kombiglyze (Saxagliptin-Metformin)

  • Indicated for: Controlling high blood sugar (hyperglycemia) in adults with type 2 diabetes.
  • Status: Available now.

Onglyza (Saxagliptin)

  • Indicated for: Controlling high blood sugar (hyperglycemia) in people with type 2 diabetes.
  • Status: Available now.

Current drug shortages*


Diclofenac sodium 1% topical gel

  • Indicated for: Treatment of acute pain or osteoarthritis.
  • Status: Recovery TBD.
  • Alternatives: Ask your Genoa pharmacist for alternative options.

*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.

Recent Posts

  • Pharmacy Openings
Announcing four new pharmacy openings!

We’re excited to announce the opening of four pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Genoa in the News
Genoa Healthcare® Chief Executive Officer provides industry outlook in Chain Drug Review article

In the health care industry in 2024, pharmacy teams will continue to play a critical role in providing care in areas with limited access to pharmacy services. Genoa Healthcare Chief...

  • Clinical Insights
February 2024 drug trend report

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to...

  • Clinical Insights
Uzedy™: Long-acting injection for the treatment of schizophrenia

Learn more about this new treatment option for adults living with schizophrenia Genoa is here to help keep you informed on the latest in behavioral health medications. Read on to...